Skip to main content

Advertisement

Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Vitamin D modifies the associations between circulating betatrophin and cardiometabolic risk factors among youths at risk for metabolic syndrome

Fig. 1

Levels of betatrophin in various metabolic abnormalities. Betatrophin concentrations were compared between subjects with and without a central obesity, b elevated blood pressures, c high TG, d low HDL-C and g NAFLD, and subjects with different e glucose tolerance status (normal, IGT/IFG, or T2DM, f number of MS components (0, 1, 2, or ≥ 3) and h vitamin D tertile ( T1, 3.00–11.94 ng/ml; T2, 11.94–17.04 ng/ml; and T3, 17.04–35.61 ng/ml). Data are natural log-transformed and shown as mean ± SEM. All P values were adjusted for gender and age and P* was further adjusted for vitamin D levels. NS no significant difference; TG triglycerides; HDL-C high-density lipoprotein cholesterol; MS metabolic syndrome; IFG impaired fasting glucose; IGT impaired glucose tolerance; T2DM type 2 diabetes mellitus; NAFLD nonalcoholic fatty liver disease

Back to article page